Canaccord lowered the firm’s price target on AdaptHealth (AHCO) to $13 from $14 and keeps a Buy rating on the shares. The firm said they maintain their rating although they expect it will be several quarters for catalysts to emerge to drive shares higher.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHCO:
- AdaptHealth price target lowered to $14 from $16 at Baird
- AdaptHealth Reports Q3 2024 Financial Results
- Morning Movers: GlobalFoundries and Apollo Global gain following Q3 results
- AdaptHealth revises FY24 revenue view to $ $3.22B-$3.26B, consensus $3.28B
- AdaptHealth reports Q3 EPS 15c, consensus 17c